The company is engaged in the development of a saffron cultivation protocol intended for the food industry, pharma and nutritional supplements. Production is set to begin soon.
02.03.2022 - Naveh Pharma currently achieves annual revenues of $1.3m and a net profit of $300,000 and is growing at 30% per year Joint Venture creates a gateway for Saffron Tech to continue its R&D efforts with the new revenue stream. Saffron Tech . Seite 1